Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Wai Yuen Tong Medicine Holdings Limited ( (HK:0897) ) is now available.
Wai Yuen Tong Medicine Holdings Limited reported a decline in its interim financial results for the six months ended September 30, 2025, with revenue decreasing by 6.9% and profit attributable to owners dropping by 88.2% compared to the same period in 2024. Despite the challenging financial performance, the company maintained a stable net asset value and slightly improved its gearing ratio, indicating a cautious approach to financial management amid market challenges.
The most recent analyst rating on (HK:0897) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Wai Yuen Tong Medicine Holdings Limited stock, see the HK:0897 Stock Forecast page.
More about Wai Yuen Tong Medicine Holdings Limited
Wai Yuen Tong Medicine Holdings Limited is a company incorporated in Bermuda, primarily engaged in the production and sale of traditional Chinese medicine and health products. The company operates in the healthcare industry and focuses on providing herbal remedies and wellness solutions.
Average Trading Volume: 1,222,995
Technical Sentiment Signal: Buy
Current Market Cap: HK$478.2M
For a thorough assessment of 0897 stock, go to TipRanks’ Stock Analysis page.